For: | Fonseka LN, Woo BK. Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review. World J Psychiatry 2023; 13(5): 182-190 [PMID: 37303932 DOI: 10.5498/wjp.v13.i5.182] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i5/182.htm |
Number | Citing Articles |
1 |
Abraham Rudnick, Andrea Shaheen, Sarah Lefurgey, Dougal Nolan. Operational Stress Injury. Encyclopedia 2023; 3(4): 1332 doi: 10.3390/encyclopedia3040095
|
2 |
Mihai Avram, Lydia Fortea, Lea Wollner, Ricarda Coenen, Alexandra Korda, Helena Rogg, Friederike Holze, Patrick Vizeli, Laura Ley, Joaquim Radua, Felix Müller, Matthias E. Liechti, Stefan Borgwardt. Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine. Molecular Psychiatry 2024; doi: 10.1038/s41380-024-02734-y
|
3 |
Francisco J. Appiani, Stanley N. Caroff. The cyclical revival of psychedelics in psychiatric treatment. Current Medical Research and Opinion 2024; 40(8): 1389 doi: 10.1080/03007995.2024.2368725
|
4 |
Isabel Werle, Leandro J. Bertoglio. Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents. Neuroscience & Biobehavioral Reviews 2024; 167: 105899 doi: 10.1016/j.neubiorev.2024.105899
|
5 |
Fatima Iftikhar Shah, Somia Shehzadi, Fatima Akram, Ikram ul Haq, Benish Javed, Sadeed Sabir, Yasha Kazim, Sehrish Ashfaq. Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy. Molecular Biotechnology 2023; doi: 10.1007/s12033-023-00994-7
|